Developmental toxicity of orally administered sildenafil citrate (Viagra) in SWR/J mice

Saudi Journal of Biological Sciences

Volumn 18, Issue 2, 2011, Pages 135-139

  Abou Tarboush, Faisal Mohamed ^a   Abdel Samad, Mohamed Fathy ^a   Al Meteri, Mokhlid Hamed ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Developmental toxicity; Embryo fetal toxicity; Growth suppressing effect; Mice; Sildenafil citrate; Teratogenic effect; Viagra

Indexed keywords

MUS;

EID: 79952317820     PISSN: 1319562X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjbs.2010.12.007     Document Type: Article

References (28)

1. Abbott D., Comby P., Charnel C., Graepel P., Hanton G., Leblane B., Lodola A., Longeart L., Paulus G., Peters C., Stadler J. Preclinical safety profile of sildenafil. Int. J. Impot. Res. 2004, 16(6):498-504.
2. Aldridge J., Measham F. Sildenafil (Viagra) is used as a recreational drug in England. BMJ 1999, 318:669-670.
3. Barroso R.P., Osuamkpe C., Nagamani M., Yallampalli C. Nitric oxide inhibits development of embryos and implantation in mice. Mol. Hum. Reprod. 1998, 4:503-507.
4. Blancato J.K., Seyler D.E. Effect of calcium-modifying drugs on mouse in vitro fertilization and preimplantation development. Int. J. Fertil. 1990, 35:171-176.
5. Boyce E.G., Umland E.M. Sildenafil citrate: a therapeutic update. Clin. Ther. 2001, 23(1):2-23.
6. Derchi G., Forni G.L. Therapeutic approaches to pulmonary hypertension in hemoglobinopathies: efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy. Ann. N.Y. Acad. Sci. 2005, 1054:471-475.
7. Fischmeister R., Hartzell H.C. Cyclic-AMP phosphodiesterases and Ca2+ current regulation in cardiac-cells. Life Sci. 1991, 48:2365-2376.
8. Ghalayini I.F. Nitric oxide-cGMP pathways with some emphasis on cavernosal contractility. Int. J. Impot. Res. 2004, 16:459-469.
9. Glenn D.R.J., McVicar C.M., McClure N., Lewis S.E.M. Sildenafil citrate improves sperm motility but causes a premature acrosome reaction in vitro. Fertil. Steril. 2007, 87:1064-1070.
10. Glenn D.R., McClure N., Cosby S.L., Stevenson M., Lewis S.E. Sildenafil citrate (Viagra) impairs fertilization and early development in mice. Fertil. Steril. 2009, 91(3):893-899.
11. Grealy M., Sreenan J.M. Effect of adenylyl cyclase activation on intracellular and extracellular cAMP and cGMP in preimplantation cattle blastocysts. J. Reprod. Fertil. 1999, 116:355-361.
12. Krenzelok E.P. Sildenafil: clinical toxicology profile. J. Toxicol. Clin. Toxicol. 2000, 38(6):645-651.
13. McLeod M.J. Differential staining of cartilage and bone in whole mouse fetuses by Alcian Blue and Alizarin Red S. Teratology 1980, 32:38-39.
14. Moncada S., Higgs E.A. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 1991, 21:361-374.
15. Monga M., Bernie J., Rajasekaran M. Male infertility and erectile dysfunction in spinal cord injury: a review. Arch. Phys. Med. Rehabil. 1999, 80:1331-1339.
16. Product Monograph Revatio (sildenafil citrate tablets), cGMP-Specific Phosphodiesterase type 5 Inhibitor, Treatment of Pulmonary Arterial Hypertension 2006, TMPfizer Product Inc., Canada.
17. Refuerzo J.S., Sokol R.J., Aranda J.V., Hallak M., Hotra J.W., Kruger M., Sorokin Y. Sildenafil citrate and fetal outcome in pregnant rats. Fetal Diagn. Ther. 2006, 21(3):259-263.
18. Schiano M.A., Sevin B.U., Perras J., Ramos R., Wolloch E.H., Averette H.E. In vitro enhancement of cis-platinum antitumor activity by caffeine and pentoxifylline in a human ovarian cell line. Gynecol. Oncol. 1991, 43:37-45.
19. Scott L., Smith S. Human sperm motility-enhancing agents have detrimental effects on mouse oocytes and embryos. Fertil. Steril. 1995, 63:166-175.
20. Smith K.M., Romanelli F. Recreational use and misuse of phosphodiesterase 5 inhibitors. J. Am. Pharm. Assoc. 2005, 45:63-72.
21. Sokal R.R., Rohlf F.J. Biometry: The Principles and Practice of Statistics in Biological Research 1981, W.H. Freeman and Company, San Francisco, 859pp.
22. Souness J.E., Hassall G.A., Parrott D.P. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cAMP phosphodiesterase inhibitors. Biochem. Pharmacol. 1992, 44:857-866.
23. Tournaye H., Vander Linden M., Van den Abbeel E., Devroey P., Van Steirteghem A. Effect of pentoxifylline on implantation and post-implantation development of mouse embryos in vitro. Hum. Reprod. 1993, 8:1948-1954.
24. Vatansever H.S., Kayikcioglu O., Gumus B. Histopathologic effect of chronic use of sildenafil citrate on the choroid and retina in male rats. Indian J. Med. Res. 2003, 117:211-215.
25. Villanueva-Garcia D., Mota-Rojas D., Hernandez-Gonzalez R., Sanchez-Aparicio P., Alonso-Spilsbury M., Trujillo-Ortega M.E., Necoechea R.R., Nava-Ocampo A.A. A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour. J. Obstet. Gynaecol. 2007, 27(3):255-259.
26. Wang W., Masu K., Tamura G., Suzuki K., Ohwada K., Okuyama K., et al. Inhibition of eosinophil survival by a selective inhibitor of phosphodiesterase 4 via the induction of apoptosis. Biol. Pharm. Bull. 2005, 28:515-519.
27. Webb S.E., Miller A.L. Calcium signalling during embryonic development. Nat. Rev. Mol. Cell Biol. 2003, 4:539-551.
28. Zhu B., Strada S., Stevens T. Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 2891:L196-L206.